Trial Profile
A phase III trial of tongjinshule (TJSL) in women with primary dysmenorrhoea.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Feb 2012
Price :
$35
*
At a glance
- Drugs Tongjingshule (Primary)
- Indications Dysmenorrhoea
- Focus Registrational; Therapeutic Use
- 14 Feb 2012 Aoxing Pharmaceutical Company has almost completed the analysis of data from the phase III trial, according to an Aoxing Pharmaceutical Company media release
- 28 Sep 2011 Status changed from recruiting to completed, according to an Aoxing Pharmaceutical Company media release.
- 20 Jul 2010 New trial record